Maria K Hordinsky – Projects and Grants — Experts@Minnesota

View Scopus Profile

Emailhordi001@umn.edu

Research activity per year

If you made any changes in Pure these will be visible here soon.

15 Active
20 Finished

15 results

Filter

Active
A STUDY TO EVALUATE MAINTENANCE OF HAIR REGROWTH FOLLOWINGDOSE REDUCTION OF CTP-543 IN ADULT PATIENTS WITH MODERATE TOSEVERE ALOPECIA AREATA
Hordinsky, M. K.
Concert Pharmaceuticals, Inc.
3/1/21 → 3/30/26
Project: Research project
Measuring Alopecia Areata Patient-Reported Psychosocial Outcomes: Scale Development and Validation
Hordinsky, M. K.
PFIZER, INC.
10/7/20 → 4/22/22
Project: Research project
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, 24-Week Study, with a 28-Week Open-Label Extension, to Assess the Safety and Efficacy of Etrasimod in Subjects with Moderate-to-Severe AlopeciaAreata
Hordinsky, M. K.
ARENA PHARMACEUTICALS, INC.
5/14/20 → 5/31/25
Project: Research project
A DOUBLE-BLIND, RANDOMIZED, PLACEBO-CONTROLLED STUDY TO EVALUATE THE EFFICACY AND SAFETY OF CTP-543 IN ADULT PATIENTS WITH MODERATE TO SEVERE ALOPECIA AREATA
Hordinsky, M. K.
Concert Pharmaceuticals, Inc.
5/1/20 → 7/30/25
Project: Research project
A 5-year Longitudinal Observational Study of Patients Undergoing Therapy for Immune-MediatedInflammatory Skin Conditions
Hordinsky, M. K.
TARGET PHARMASOLUTIONS, INC
4/6/20 → 4/30/25
Project: Research project
A PHASE 2B RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,MULTICENTER, DOSE-RANGING STUDY TO EVALUATE THE EFFICACY ANDSAFETY PROFILE OF PF-06651600 WITH A PARTIALLY BLINDED EXTENSIONPERIOD TO EVALUATE THE EFFICACY AND SAFETY OF PF-06651600 ANDPF-067008
Hordinsky, M. K.
PFIZER, INC.
6/20/19 → 6/30/24
Project: Research project
A PHASE 3 OPEN-LABEL, MULTI-CENTER, LONG-TERM STUDY INVESTIGATING THE SAFETY ANDEFFICACY OF PF-06651600 IN ADULT AND ADOLESCENT PARTICIPANTS WITH ALOPECIA AREATA
Hordinsky, M. K.
PFIZER, INC.
6/17/19 → 6/30/24
Project: Research project
Open-Label Study of ATI-502 Topical Solution for the Treatment of Alopecia Areata (AA), AlopeciaUniversalis (AU) and Alopecia Totalis (AT)
Hordinsky, M. K.
ACLARIS THERAPEUTICS, INC
1/4/19 → 1/31/24
Project: Research project
A Phase 2B/3 Randomized, Double-Blind, Placebo-Controlled, Dose-Ranging Study to Investigate the Efficacy and Safety of PF-06651600 in Adult and Adolescent Alopecia Areata (AA) Subjects with 50% or Greater Scalp Hair Loss
Hordinsky, M. K.
PFIZER, INC.
10/9/18 → 10/30/23
Project: Research project
WEN Shampoo Study
Farah, R. S. & Hordinsky, M. K.
CHAZ DEAN, INC.
8/27/18 → 10/31/21
Project: Research project
A Multicenter, Randomized, Double-Blind, PlaceboControlled, Operationally Seamless, Adaptive Phase 2/3Study to Evaluate the Efficacy and Safety of Baricitinib in Adult Patients with Severe or Very SevereAlopecia Areata
Hordinsky, M. K.
Eli Lilly and Company
8/6/18 → 8/30/23
Project: Research project
A Randomized, Double-Blind, Placebo-Controlled Multicenter Study to Evaluate the Safety, Tolerability andEfficacy of ATI-501 Oral Suspension Compared to Placebo in Adult Subjects with Alopecia Areata,Alopecia Universalis or Alopecia Totalis
Hordinsky, M. K.
ACLARIS THERAPEUTICS, INC
6/15/18 → 6/30/22
Project: Research project
A Randomized, Double-blind, Vehicle-controlled
Hordinsky, M. K.
ACLARIS THERAPEUTICS, INC
8/1/17 → 8/30/21
Project: Research project
A PHASE 2A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED,
Hordinsky, M. K.
PFIZER, INC.
6/21/17 → 1/30/22
Project: Research project
Mechanism of immune modulation by DPCP in alopecia
Hordinsky, M. K.
NATIONAL ALOPECIA AREATA FOUNDATION
1/1/16 → 6/30/22
Project: Research project